Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79681.300.0078%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Jasper Therapeutics Inc (JSPR) Stock Price, Quote, News & History

JSPRNASDAQ
Trade with Public
Trade with Public
$0.7086
0.02223.23%
At close: Sep 4, 5:00 PM EST
$0.7336
0.0253.53%
After Hours: 7:35 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Jasper Therapeutics (JSPR) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$0.67
Close
$0.71
Volume / Avg.
432.93K / 1.43M
Day Range
$0.66 - $0.71
52 Wk Range
0.32 - 2.83
Market Cap
$24.41M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
16.41%
Days to Cover
7.76

Recent Jasper Therapeutics, Inc. News

Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Dell Technologies (DELL) stock jumps in pre-market trading after reporting better-than-expected Q2 results and raising FY27 guidance. Other gainers include UPC, GTLB, VIVK, UFG, MLEC, FFAI, GPUS, NCPL, and LHSW.
Avi Kapoor

Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives

Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are happening.
Caroline Ryan

Jasper Closes Kira Deal, Extends Cash Runway

Jasper Therapeutics (JSPR) acquires Kira Pharma & raises $132M, extending its cash runway into 2028. Shares surge 20%+.
Vandana Singh

Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partnership with Alabama State University.
Avi Kapoor

Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate

Major M&A deals this week include: New Mountail Capital buys Asset Living, SalesForce acquires Contentful, Wellington nabs The Hartford Funds
Caroline Ryan

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-60.33M
Investing Cash Flow (TTM)
80.00K
Financing Cash Flow (TTM)
28.06M
Free Cash Flow (TTM)
-60.33M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-32.20M

Analyst Trends and Forecast

1
Mar
1
Apr
0
0
0
0
May
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$15.51M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
15.96
Earnings Yield % (TTM)
-137.19%
Earnings Yield % (FWD)
-143.83%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.04

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$7.31M
Debt to Equity
0.19
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.67
Close
$0.71
Volume / Avg.
432.93K / 1.43M
Day Range
$0.66 - $0.71
52 Wk Range
0.32 - 2.83
Market Cap
$24.41M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
16.41%
Days to Cover
7.76

About

Sector
Health Care
Industry
Biotechnology
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead p...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Jasper Therapeutics (JSPR) stock?

A

You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Jasper Therapeutics (JSPR) competitors?

Q

What is the forecast, or price target, for Jasper Therapeutics (JSPR) stock?

A

Jasper Therapeutics has a consensus price target of $25.96.

Q

What is the current price for Jasper Therapeutics (JSPR)?

A

The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $0.733583 last updated September 4, 2026 at 7:35 PM EDT.

Q

Does Jasper Therapeutics (JSPR) pay a dividend?

A

There are no upcoming dividends for Jasper Therapeutics.

Q

When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?

A

Jasper Therapeutics does not have any upcoming earnings scheduled.

Q

Is Jasper Therapeutics (JSPR) going to split?

A

There is no upcoming split for Jasper Therapeutics.

Q

What sector and industry does Jasper Therapeutics (JSPR) operate in?

A

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved